Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elliman, Sons & Co was a prominent 19th-century British pharmaceutical manufacturer based in Slough, England. Founded in 1847 by James Elliman, the company achieved international fame for its 'Elliman's Embrocation,' a topical liniment used for treating muscle and joint pain in both humans and animals. The business was a pioneer in mass-market advertising, utilizing distinctive illustrations and global distribution networks to establish its brand as a household name. In 1961, the company was acquired by Horlicks, which was later absorbed by the Beecham Group, eventually becoming part of the GSK portfolio. While the independent company no longer exists, it remains a significant case study in the history of pharmaceutical branding and consumer healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elliman, Sons & Co.